Cogent Biosciences (COGT) Shares Outstanding (Weighted Average): 2017-2024
Historic Shares Outstanding (Weighted Average) for Cogent Biosciences (COGT) over the last 8 years, with Dec 2024 value amounting to $110.5 million.
- Cogent Biosciences' Shares Outstanding (Weighted Average) rose 251.35% to $39.9 million in Q4 2021 from the same period last year, while for Sep 2021 it was $39.8 million, marking a year-over-year increase of 316.58%. This contributed to the annual value of $110.5 million for FY2024, which is 28.26% up from last year.
- Cogent Biosciences' Shares Outstanding (Weighted Average) amounted to $110.5 million in FY2024, which was up 28.26% from $86.1 million recorded in FY2023.
- In the past 5 years, Cogent Biosciences' Shares Outstanding (Weighted Average) ranged from a high of $110.5 million in FY2024 and a low of $11.3 million during FY2020.
- Moreover, its 3-year median value for Shares Outstanding (Weighted Average) was $86.1 million (2023), whereas its average is $88.8 million.
- Data for Cogent Biosciences' Shares Outstanding (Weighted Average) shows a peak YoY surged of 251.35% (in 2021) over the last 5 years.
- Yearly analysis of 5 years shows Cogent Biosciences' Shares Outstanding (Weighted Average) stood at $11.3 million in 2020, then soared by 251.35% to $39.9 million in 2021, then spiked by 75.39% to $69.9 million in 2022, then grew by 23.22% to $86.1 million in 2023, then rose by 28.26% to $110.5 million in 2024.